Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for Notalgia Paresthetica
NCT01098019Phase 3Completed
- Sponsor
- Innovaderm Research
- Start
- Apr 2010
- Primary completion
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in notalgia paresthetica (NP), sponsored by Innovaderm Research. Started Apr 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
notalgia paresthetica (NP)
Beyond the preview
Go deeper on NCT01098019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098019.